External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.
Andrew T KunzmannAaron P ThriftBrian T JohnstonDamian T McManusAnna T GavinRichard C TurkingtonHelen G ColemanPublished in: Alimentary pharmacology & therapeutics (2019)
This external validation provides further evidence that a model based on sex, smoking, Barrett's segment length and baseline low-grade dysplasia may help to risk stratify patients after an initial diagnosis of Barrett's oesophagus. The model also performed better than the use of low-grade dysplasia status alone for risk-stratification.